Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The CRCHUM-MT cocktail is a CYP450 probe drug cocktail used in clinical research to evaluate the activity of seven major CYP450 drug-metabolizing enzymes. It consists of caffeine (CYP1A2), bupropion (CYP2B6), tolbutamide (CYP2C9), omeprazole (CYP2C19), dextromethorphan (CYP2D6), and midazolam (CYP3As), with chlorzoxazone (CYP2E1) administered separately. This cocktail is primarily used in research settings to assess how various conditions, such as type 2 diabetes mellitus, affect drug metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CRCHUM-MT cocktail.